You're going to hear a lot more about "aspirin resistance"

You're going to hear a lot more about "aspirin resistance."

Now that millions of people take low-dose aspirin to prevent cardiovascular disease, we're seeing that it doesn't always work.

About 10% of the population might be resistant to aspirin's antiplatelet effects. These patients might be up to 3 times more likely to have a heart attack or stroke.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote